Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Improvement in Tuberculosis Outcomes With a Combined Medical and Social Approach.

Mazza-Stalder J, Chevallier E, Opota O, Carreira A, Jaton K, Masserey E, Zellweger JP, Nicod LP.

Front Med (Lausanne). 2019 Jun 21;6:135. doi: 10.3389/fmed.2019.00135. eCollection 2019.

2.

Towards better management of latent tuberculosis infection in children and young adults in the Maghreb. Conclusions of an expert meeting, Paris, 16 March 2018.

Delacourt C, Zellweger JP; Maghreb pediatric TB expert group.

Arch Pediatr. 2019 Feb;26(2):126-129. doi: 10.1016/j.arcped.2018.12.001. Epub 2019 Jan 11. No abstract available.

PMID:
30642745
3.

Health-seeking behaviour and treatment delay in patients with pulmonary tuberculosis in Switzerland: some slip through the net.

Auer C, Kiefer S, Zuske M, Schindler C, Wyss K, Blum J, Bosch-Capblanch X, Widmer U, Sauthier S, Janssens JP, Bossard K, Chatonnet C, Mazza-Stalder J, Začek B, Zellweger JP, Altpeter E, Mäusezahl M.

Swiss Med Wkly. 2018 Sep 6;148:w14659. doi: smw.2018.14659. eCollection 2018 Aug 27.

4.

Predicting tuberculosis: the blood, the skin, or the Sibyl?

Zellweger JP.

Lancet Infect Dis. 2018 Oct;18(10):1048-1049. doi: 10.1016/S1473-3099(18)30398-0. Epub 2018 Aug 30. No abstract available.

5.

Multidrug-resistant tuberculosis in Ukraine: what is hidden behind the numbers?

Zellweger JP.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):966-967. doi: 10.5588/ijtld.18.0147. No abstract available.

PMID:
29991409
6.

Depression and risk of tuberculosis.

Zellweger JP.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1314. doi: 10.5588/ijtld.17.0436. No abstract available.

PMID:
29297453
7.

Migration, TB control and elimination: Whom to screen and treat.

Rendon A, Centis R, Zellweger JP, Solovic I, Torres-Duque CA, Robalo Cordeiro C, de Queiroz Mello FC, Manissero D, Sotgiu G.

Pulmonology. 2018 Mar - Apr;24(2):99-105. doi: 10.1016/j.rppnen.2017.11.007. Epub 2017 Dec 29. Review.

8.

Migrant screening for tuberculosis and LTBI in Europe.

Zellweger JP, Posey DL.

Int J Tuberc Lung Dis. 2017 Aug 1;21(8):835. doi: 10.5588/ijtld.17.0374. No abstract available.

PMID:
28786788
9.

Latent tuberculosis infection in rural China: who will develop tuberculosis?

Zellweger JP.

Lancet Infect Dis. 2017 Oct;17(10):1007-1008. doi: 10.1016/S1473-3099(17)30441-3. Epub 2017 Jul 14. No abstract available.

PMID:
28716676
10.

Investigations for tuberculosis contacts: what are the real issues of all the efforts?

Zellweger JP.

Thorax. 2017 Aug;72(8):679. doi: 10.1136/thoraxjnl-2017-210110. Epub 2017 Apr 17. No abstract available.

PMID:
28416591
11.

Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.

Adjobimey M, Masserey E, Adjonou C, Gbénagnon G, Schwoebel V, Anagonou S, Zellweger JP.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1055-9. doi: 10.5588/ijtld.15.0493.

PMID:
27393539
12.

Bacille Calmette-Guérin injection instead of purified protein derivative injection in an infliximab treated patient.

Aegerter JP, Christin L, Guyot J, Zellweger JP.

Int J Tuberc Lung Dis. 2016 Jul;20(7):990-1. doi: 10.5588/ijtld.16.0107. No abstract available.

PMID:
27287659
13.

Impact of migration on tuberculosis epidemiology and control in the EU/EEA.

van der Werf MJ, Zellweger JP.

Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30174. No abstract available.

14.

[Smoking cessation: how do we help the smokers?].

Zellweger JP.

Rev Med Suisse. 2016 Jan 27;12(503):204-5. French. No abstract available.

PMID:
26939183
15.

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR Jr, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.

Eur Respir J. 2015 Dec;46(6):1563-76. doi: 10.1183/13993003.01245-2015. Epub 2015 Sep 24. Review.

16.

Screening and smoking cessation support for TB contacts: cost-effective good clinical practice.

Zellweger JP.

Int J Tuberc Lung Dis. 2015 Jul;19(7):750. doi: 10.5588/ijtld.15.0374. No abstract available.

PMID:
26056097
17.

Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies.

Zellweger JP, Bodmer T, Bischler U, Mykychak M, Nakonetchny S, Rak L.

Int J Tuberc Lung Dis. 2015 Apr;19(4):493-4. doi: 10.5588/ijtld.14.0857. No abstract available.

PMID:
25860009
18.

[Against e-cigarette].

Zellweger JP.

Rev Med Suisse. 2015 Jan 28;11(459):242-3. French. No abstract available.

PMID:
25845158
19.

Towards tuberculosis elimination: an action framework for low-incidence countries.

Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau MA, Goletti D, González Ochoa ER, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Tayeb T, van der Werf MJ, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MR, Aliberti S, Arrazola de Oñate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle UR, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, Del Granado M, Haas W, Järvinen A, Kwon GY, Mosca D, Nahid P, Nishikiori N, Noguer I, O'Donnell J, Pace-Asciak A, Pompa MG, Popescu GG, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Torres-Duque CA, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr;45(4):928-52. doi: 10.1183/09031936.00214014. Review.

20.

Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.

Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET.

Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84. doi: 10.1164/rccm.201502-0232OC.

PMID:
25763458
21.

Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking?

Zellweger JP, Cattamanchi A, Sotgiu G.

Eur Respir J. 2015 Mar;45(3):583-5. doi: 10.1183/09031936.00221814. No abstract available.

22.

How frequent is latent tuberculosis infection in China?

Zellweger JP.

Lancet Infect Dis. 2015 Mar;15(3):256-8. doi: 10.1016/S1473-3099(15)70040-X. Epub 2015 Feb 11. No abstract available.

PMID:
25681062
23.

Managing an extensively drug-resistant tuberculosis outbreak: the public health face of the medal.

Codecasa LR, Ciconali G, Mazzola E, Ferrarese M, Cirillo D, Borroni E, Gesu GP, Zellweger JP, Centis R, Faccini M.

Eur Respir J. 2015 Jan;45(1):292-4. doi: 10.1183/09031936.00134114. No abstract available.

24.

Treatment outcomes of multidrug-resistant tuberculosis in Switzerland.

Helbling P, Altpeter E, Egger JM, Zellweger JP.

Swiss Med Wkly. 2014 Dec 4;144:w14053. doi: 10.4414/smw.2014.14053. eCollection 2014.

25.

Drug resistance and tuberculosis elimination in low-incidence countries.

Falzon D, Zellweger JP, Migliori GB, Jaramillo E.

Eur Respir J. 2014 Dec;44(6):1408-11. doi: 10.1183/09031936.00138014. No abstract available.

26.

Contact tracing investigation after professional exposure to tuberculosis in a Swiss hospital using both tuberculin skin test and IGRA.

Balmelli C, Zysset F, Pagnamenta A, Francioli P, Lazor-Blanchet C, Zanetti G, Zellweger JP.

Swiss Med Wkly. 2014 Aug 14;144:w13988. doi: 10.4414/smw.2014.13988. eCollection 2014.

27.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

28.

Serial screening for latent tuberculosis infection in healthcare workers in low-risk settings.

Zellweger JP, Rieder HL.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):3-4. doi: 10.1164/rccm.201311-2062ED. No abstract available.

PMID:
24381985
29.

Bacille Calmette-Guérin vaccination: the current situation in Europe.

Dara M, Acosta CD, Rusovich V, Zellweger JP, Centis R, Migliori GB; WHO EURO Childhood Task Force members.

Eur Respir J. 2014 Jan;43(1):24-35. doi: 10.1183/09031936.00113413. No abstract available.

30.

High rate of completion of preventive therapy for latent tuberculosis infection among asylum seekers in a Swiss Canton.

Sarivalasis A, Bodenmann P, Langenskiold E, Lutchmaya-Flick C, Daher O, Zellweger JP.

Swiss Med Wkly. 2013 Sep 6;143:w13860. doi: 10.4414/smw.2013.13860. eCollection 2013.

31.

Current issues in the management of tuberculosis in Europe.

Zellweger JP.

Panminerva Med. 2013 Jun;55(2):145-55. Review.

PMID:
23676956
32.

The history and evolution of immigration medical screening for tuberculosis.

Dara M, Gushulak BD, Posey DL, Zellweger JP, Migliori GB.

Expert Rev Anti Infect Ther. 2013 Feb;11(2):137-46. doi: 10.1586/eri.12.168.

PMID:
23409820
33.

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.

Diel R, Loddenkemper R, Zellweger JP, Sotgiu G, D'Ambrosio L, Centis R, van der Werf MJ, Dara M, Detjen A, Gondrie P, Reichman L, Blasi F, Migliori GB; European Forum for TB Innovation.

Eur Respir J. 2013 Sep;42(3):785-801. doi: 10.1183/09031936.00205512. Epub 2013 Feb 8.

34.

[Multiresistant tuberculosis and surgical resection].

Zellweger JP.

Rev Mal Respir. 2012 Dec;29(10):1273-4. doi: 10.1016/j.rmr.2012.06.010. Epub 2012 Oct 12. French. No abstract available.

PMID:
23228686
35.

Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County.

Sarivalasis A, Zellweger JP, Faouzi M, Daher O, Deslarzes C, Bodenmann P.

BMC Infect Dis. 2012 Nov 2;12:285. doi: 10.1186/1471-2334-12-285.

36.

Availability of anti-tuberculosis drugs in Europe.

Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.

Eur Respir J. 2012 Aug;40(2):500-3. doi: 10.1183/09031936.00009212. No abstract available.

37.

Medical students and doctors who smoke and their patients.

Zellweger JP.

Int J Tuberc Lung Dis. 2012 Aug;16(8):997. doi: 10.5588/ijtld.12.0482. No abstract available.

PMID:
22762422
38.

Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement.

Dara M, de Colombani P, Petrova-Benedict R, Centis R, Zellweger JP, Sandgren A, Heldal E, Sotgiu G, Jansen N, Bahtijarevic R, Migliori GB; Wolfheze Transborder Migration Task Force.

Eur Respir J. 2012 Nov;40(5):1081-90. doi: 10.1183/09031936.00053012. Epub 2012 May 31. Review.

39.

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.

Sotgiu G, Centis R, D'Ambrosio L, Alffenaar JW, Anger HA, Caminero JA, Castiglia P, De Lorenzo S, Ferrara G, Koh WJ, Schecter GF, Shim TS, Singla R, Skrahina A, Spanevello A, Udwadia ZF, Villar M, Zampogna E, Zellweger JP, Zumla A, Migliori GB.

Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10. Review.

40.

European union standards for tuberculosis care.

Migliori GB, Zellweger JP, Abubakar I, Ibraim E, Caminero JA, De Vries G, D'Ambrosio L, Centis R, Sotgiu G, Menegale O, Kliiman K, Aksamit T, Cirillo DM, Danilovits M, Dara M, Dheda K, Dinh-Xuan AT, Kluge H, Lange C, Leimane V, Loddenkemper R, Nicod LP, Raviglione MC, Spanevello A, Thomsen VØ, Villar M, Wanlin M, Wedzicha JA, Zumla A, Blasi F, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2012 Apr;39(4):807-19. doi: 10.1183/09031936.00203811.

41.

[Smoking cessation in medical practice--new possibilities?].

Schuurmans MM, Zellweger JP.

Rev Med Suisse. 2012 Jan 25;8(325):235-6. Review. German. No abstract available.

PMID:
22338532
42.

TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

Migliori GB, Sotgiu G, D'Ambrosio L, Centis R, Lange C, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Manissero D.

Eur Respir J. 2012 Mar;39(3):619-25. doi: 10.1183/09031936.00170411. Epub 2012 Feb 9.

43.

Improved health of hospitality workers after a Swiss cantonal smoking ban.

Durham AD, Bergier S, Morisod X, Locatelli I, Zellweger JP, Huynh CK, Cornuz J.

Swiss Med Wkly. 2011 Dec 22;141:w13317. doi: 10.4414/smw.2011.13317. eCollection 2011.

44.

[Multidrug resistant tuberculosis -- its extent, hazard and possible solutions].

Zellweger JP.

Rev Mal Respir. 2011 Oct;28(8):1025-33. doi: 10.1016/j.rmr.2010.10.040. Epub 2011 Oct 1. Review. French.

PMID:
22099408
45.

TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

Sotgiu G, D'Ambrosio L, Centis R, Bothamley G, Cirillo DM, De Lorenzo S, Guenther G, Kliiman K, Muetterlein R, Spinu V, Villar M, Zellweger JP, Sandgren A, Huitric E, Lange C, Manissero D, Migliori GB.

Eur Respir J. 2011 Nov;38(5):1221-3. doi: 10.1183/09031936.00029311. No abstract available.

46.

[Tuberculosis in Switzerland].

Brändli O, Zellweger JP.

Ther Umsch. 2011 Jul;68(7):365-8. doi: 10.1024/0040-5930/a000178. Review. German.

PMID:
21728153
47.

Influence of pre-analytic conditions on the rate of indeterminate T-SPOT.TB tests.

Zellweger A, Zellweger JP.

Eur Respir J. 2011 Jul;38(1):221-2. doi: 10.1183/09031936.00179310. No abstract available.

48.

[New recommendations for contact tracing in tuberculosis].

Diel R, Loytved G, Nienhaus A, Castell S, Detjen A, Geerdes-Fenge H, Haas W, Hauer B, Königstein B, Maffei D, Magdorf K, Priwitzer M, Zellweger JP, Loddenkemper R.

Gesundheitswesen. 2011 Jun;73(6):369-88. doi: 10.1055/s-0030-1256574. Epub 2011 Jun 21. German.

PMID:
21695661
49.

[New recommendations for contact tracing in tuberculosis. German Central Committee against Tuberculosis].

Diel R, Loytved G, Nienhaus A, Castell S, Detjen A, Geerdes-Fenge H, Haas W, Hauer B, Königstein B, Maffei D, Magdorf K, Priwitzer M, Zellweger JP, Loddenkemper R.

Pneumologie. 2011 Jun;65(6):359-78. doi: 10.1055/s-0030-1256439. Epub 2011 May 10. German. Erratum in: Pneumologie. 2011 Jun;65(6):e50.

50.

Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D.

Eur Respir J. 2011 Jan;37(1):88-99. doi: 10.1183/09031936.00115110. Epub 2010 Oct 28. Review. Erratum in: Eur Respir J. 2012 Mar;39(3):793.

Supplemental Content

Loading ...
Support Center